SABCS 2023丨An Interview with Dr. Santiago Escriva-de-Romanion the Novel Zaniratamab Combinations for HR+/HER2+ mBC
Editor's Note: At the 2023 SABCS congress, We interviewed with Dr. Santiago Escriva-de-Romani from Vall d’Hebron Institute of Oncology (VHIO), explored the revolutionary advancements in breast cancer treatment, focusing on the introduction of the…
